DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Drugs Industry: Global Competitive Landscape 2021” report has been added to ResearchAndMarkets.com’s offering.
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail.
The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.
Report Includes
- A brief general overview of the global pharmaceutical drugs industry competitive landscape
- Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
- Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
- Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
- Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
- Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila
This report discusses the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well-researched and analyzed in this report.
Study Goals and Objectives:
The goals and objectives of this study include:
- Defining and discussing the competitive landscape of the global pharmaceutical drugs market in 2021.
- Competitive ranking of the top fifty pharmaceutical companies in the market
- Profiling major players and analyzing market share, core competencies and strategies in the pharmaceutical drugs market.
- Tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market.
Reasons for Doing This Study
With long life expectancy and emerging economies increasing their expenditure on healthcare, there is an increased demand for technologically superior pharmaceutical drugs. More stringent regulations, specifically in the mature markets of the U.S. and Europe, compel pharmaceutical manufacturers to launch sophisticated drugs that incorporate new materials, focus on in-depth indications and generate additional new data.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Market and Technology Background
Chapter 3 Impact of Covid-19 on the Pharmaceutical Drug Market
Chapter 4 Regulatory Structure: Pharmaceutical Drug Market
Chapter 5 Pricing and Reimbursement: Pharmaceuticals and Biologics
Chapter 6 Pharmaceutical Drugs Industry: Competitive Landscape
Chapter 7 Company Profiles
Companies Mentioned
- A. Menarini Industrie Farmaceutiche Riunite S.R.L.
- Abbott
- Abbvie Inc.
- Alexion Pharmaceuticals Inc.
- Amgen Inc.
- Asahi Kasei Corp.
- Astellas Pharma Inc.
- Astrazeneca
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Bayer AG
- Biogen
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Company
- China National Pharmaceutical Group Corp. (Sinopharm)
- Chugai Pharmaceutical Co. Ltd.
- Csl Ltd.
- Daiichi Sankyo Co. Ltd.
- Dr. Reddy’S Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Endo International plc
- F. Hoffmann-La Roche Ltd. (Roche)
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Grifols S.A.
- H. Lundbeck A/S
- Incyte
- Ipsen Pharma
- Johnson & Johnson Services Inc.
- Mallinckrodt plc
- Merck & Co. Inc.
- Merck Kgaa
- Moderna Inc.
- Novartis AG
- Novo Nordisk A/S
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi
- Servier Laboratories
- Shanghai Pharmaceuticals Holding
- Shionogi & Co. Ltd.
- Stada Arzneimittel AG
- Sumitomo Pharma Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Ucb S.A.
- Vertex Pharmaceuticals Inc.
- Viatris Inc.
- Zydus Cadila
For more information about this report visit https://www.researchandmarkets.com/r/mp61qv.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900